Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review

October 2021 | 55 pages | ID: N2865AFDEE0EN
GlobalData

Abstracts

Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Natco Pharma Ltd (Natco Pharma) focuses on the discovery, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosages in capsule, injection and tablet forms. Its products are indicated to treat multiple sclerosis, influenza infection, multiple myeloma, leukemia, Crohn's disease, hypertension, Myelodysplastic syndrome, prostate cancer and others. Natco Pharma offers active pharmaceutical ingredients (APIs) in the domestic and international markets. It operates API and finished dosage facilities and a research center in India. The company operates in India, the US, Canada, and Europe. Natco Pharma is headquartered in Hyderabad, Telangana, India.

Natco Pharma Ltd Key Recent Developments

Aug 12,2021: NATCO records INR 427.30 crore consolidated revenue and INR 75 crore of profit, after tax, for the first quarter ended 30th June 2021
Aug 09,2021: Natco Pharma Announces Q1 FY22 Earnings call
Jul 07,2021: NATCO: Legal Update
Jun 17,2021: NATCO records INR 2155.7 crore consolidated revenue and INR 442.4 crore of profit, after tax, for the full year ended March 2021
Jun 17,2021: Natco Pharma Announces Statement of Standalone financial results for the quarter and year ended March 31, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Natco Pharma Ltd - Key Facts
Natco Pharma Ltd - Key Employees
Natco Pharma Ltd - Key Employee Biographies
Natco Pharma Ltd - Major Products and Services
Natco Pharma Ltd - History
Natco Pharma Ltd - Company Statement
Natco Pharma Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Natco Pharma Ltd - Business Description
Business Segment: Active Pharmaceutical Ingredients
Overview
Performance
Key Stats
Business Segment: Crop Health Sciences
Overview
Performance
Key Stats
Business Segment: Domestic Formulations
Overview
Performance
Key Stats
Business Segment: International Formulations
Overview
Performance
Key Stats
Business Segment: Other Operating and Non-Operating Incomes
Performance
Geographical Segment: India
Performance
Geographical Segment: Rest of the world
Performance
Geographical Segment: The US
Performance
R&D Overview
Natco Pharma Ltd - Corporate Strategy
Natco Pharma Ltd - SWOT Analysis
SWOT Analysis - Overview
Natco Pharma Ltd - Strengths
Natco Pharma Ltd - Weaknesses
Natco Pharma Ltd - Opportunities
Natco Pharma Ltd - Threats
Natco Pharma Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Natco Pharma Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 12, 2021: NATCO records INR 427.30 crore consolidated revenue and INR 75 crore of profit, after tax, for the first quarter ended 30th June 2021
Aug 09, 2021: Natco Pharma Announces Q1 FY22 Earnings call
Jul 07, 2021: NATCO: Legal Update
Jun 17, 2021: NATCO records INR 2155.7 crore consolidated revenue and INR 442.4 crore of profit, after tax, for the full year ended March 2021
Jun 17, 2021: Natco Pharma Announces Statement of Standalone financial results for the quarter and year ended March 31, 2021
May 28, 2021: Zydus Cadila files for DCGI approval to study Covid-19 drug in India
May 17, 2021: Natco Pharma and Lilly sign licencing deal for baricitinib use in India
Feb 11, 2021: Investec invites you to the Q3 FY21 Earnings call of Natco Pharma
Feb 11, 2021: NATCO records INR 386.0 Crore consolidated revenue and INR 63.4 Crore of profit, after tax, for the Third Quarter, FY2020-21
Nov 12, 2020: NATCO records INR 827.90 Crore consolidated revenue and INR 203.90 Crore of profit after tax, for the Second Quarter, FY2020-2112

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Natco Pharma Ltd, Key Facts
Natco Pharma Ltd, Key Employees
Natco Pharma Ltd, Key Employee Biographies
Natco Pharma Ltd, Major Products and Services
Natco Pharma Ltd, History
Natco Pharma Ltd, Other Locations
Natco Pharma Ltd, Subsidiaries
Natco Pharma Ltd, Joint Venture
Natco Pharma Ltd, Key Competitors
Natco Pharma Ltd, Ratios based on current share price
Natco Pharma Ltd, Annual Ratios
Natco Pharma Ltd, Annual Ratios (Cont...1)
Natco Pharma Ltd, Annual Ratios (Cont...2)
Natco Pharma Ltd, Interim Ratios
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Natco Pharma Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Natco Pharma Ltd, Performance Chart (2017 - 2021)
Natco Pharma Ltd, Ratio Charts
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021